Mechanism identified for HBsAg reduction with Aligos Therapeutics STOPS molecule ALG-10000 July 9, 2021
Aicuris heads for phase III with herpes drug pritelivir July 8, 2021 By Richard Staines Aicuris Anti-Infective Cures AG is beginning the pivotal phase III part of its trial of pritelivir for herpes simplex virus infection after an encouraging midstage readout.Read More
RSS